SUNITINIB MALATE

Shubham Pharmaceuticals
SUNITINIB MALATE

Product Code : 150

 

Product Description

SUNITINIB MALATE:

SUTENT contains the Drug / Molecule Sunitinib Malate.

 

USAGE & DISCRIPTION :

SUTENT has used for the treatment of Gastrointestinal Stromal Tumor after disease progression on or intolerance to Imatinib Mesylate. It is also indicated for thetreatment of Advance Renal Cell Carcinoma. 

 

ACTIVE INGREDIENTS

SUNITINIB MALATE

BRAND NAME

SUTENT

PACKING

1*30 (BOTTLE) 1*7(STRIP)

DOSES FORM

CAPSULES (IN PLASTIC BOTTLE & STRIP )

STRENGTH

12.5 MG,25 MG & 50 MG

MFG BY

PFIZER

 

CLINICAL APPLICATIONS :

Sunitinib inhibits cellular signaling by targeting multiple receptor tyrosine kinases (RTKs).These include all receptors for platelet-derived growth factor (PDGF-Rs) and vascular endothelial growth facto rreceptors (VEGFRs), which play a role in both tumor angiogenesis and tumor cell proliferation. The simultaneousinhibition of these targets therefore leads to both reduced tumor vascularization and cancer cell death, and ultimately tumor shrinkage.

 

STORAGE:

Store in a cool place, protect from light.

 

Trade Information

  • Main Export Market(s)
  • Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia